Screening Of Antagonistic Activity Of Marine Actinomycetes - amazonia.fiocruz.br

Screening Of Antagonistic Activity Of Marine Actinomycetes - really

DOI: ORCiD: orcid. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. FullText PDF. The highest numbers of Enterococci were recorded from the pus 20 isolates, Enterococcus species are Gram-positive cocci usually present in the human and sometimes become severely infectious agents; particularly they are frequently find novel mechanisms to evade the antibiotics treatments [1,2].

Screening Of Antagonistic Activity Of Marine Actinomycetes - something is

Toggle navigation. Login Categories Journals. Publications Publications Authors. Translate page:. Allergy and Immunology Cardiology Clinical Procedures

Screening Of Antagonistic Activity Of Marine Actinomycetes Video

Actinomycetes and the biocontol of plant pathogens Screening Of Antagonistic Activity Of Marine Actinomycetes

New York, Nov. Over the years, a number of such modulators, capable of either activating or downregulating the STING pathway, have been developed.

Publication Analysis

More than 50 experimental interventions based on this Screeninng novel concept are currently being developed for the treatment of oncological, autoimmune and inflammatory disorders. Moreover, capital investments worth over USD 2. In addition, there have been multiple, high value technology licensing deals in this domain, since As a result, there has been a considerable rise in number of companies taking initiatives in this field, over the past years alone. Therefore, rapid assessments of STING polymorphisms may actually be useful in identifying individuals who are at high risks of contracting a severe form of this infection.

د actinomycetes د لټونی نتایج

Further, a better understanding of the underlying mechanisms associated with the novel coronavirus induced STING-pathway over-activation, may enable the development of potential therapeutic candidates against COVID However, some promising leads are anticipated to be launched over the coming decade, following which Screening Of Antagonistic Activity Of Marine Actinomycetes market is projected to grow Industrial Revolution a substantial pace. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain.

In addition to other elements, the study includes: - Source detailed assessment of the current market landscape of therapeutics targeting STING pathway, based on several parameters, such as type of STING modulator agonist or antagonisttype of molecule small molecules, cyclic dinucleotides, non-nucleotides, biologics and othersphase of development discovery, preclinical and clinicaltarget therapeutic area stype of therapy monotherapy and combination therapyroute of administration intratumoral, intravenous and othersand line of treatment last line, second line or greater and first line or greater.

The chapter also features an analysis of the developer landscape including information on year of establishment, company size, geography and most active players.

Similar Publications

Further the chapter includes an analysis on the clinical trials focused on STING, along with information on parameters, such as recruitment status, study design and clinical endpoints. Additionally, each drug profile features information on the type of drug, route of administration, target indications and current status of development.

It also includes an analysis of on grant attractiveness. In addition, the chapter features a benchmarking analysis of the aforementioned players. It also highlights the key trends observed across publications, including information on type of publication, year of publication, study objective, popular keywords, type of STING modulator, target pathway, therapeutic area, type of publisher, leading players in terms of number of publicationsregion, first author organization and key journals in terms of number of articles published in this domain. The chapter highlights analysis based on year of partnerships, type of partnership model, type of STING modulator, therapeutic area, technology platform, most active player s in terms of number of partnerships inkedand region. The chapter highlights analysis Screening Of Antagonistic Activity Of Marine Actinomycetes on the number of funding instances, amount invested, type of funding, type of STING modulator, therapeutic area, technology platform, most active player s in terms of number of funding instancesmost active investor s in terms of number of funding instances and geographical region.

One of the key objectives of the report was to estimate the existing market size and identify potential future growth opportunities for novel technologies designed for the development of STING pathway modulators.

Based on the likely licensing deal structures and agreements that are expected to be signed in the foreseen future, we have provided an informed estimate on the evolution of the market over the period The opinions and insights presented in this study were influenced by discussions conducted with several stakeholders in this domain.

Financial figures mentioned in this report are in USD, unless otherwise specified.

For all our projects, we conduct interviews with experts in the area academia, industry and other associations to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of Activitu